Showing results (101-110 of 116) with videos related to

Sort By:
Pageof 12
Current Medicinal Chemistry|August 13, 2015
Role of Serum and Glucocorticoid-Inducible Kinase (SGK)-1 in Senescence: A Novel Molecular Target Against Age-Related DiseasesD Lauro, D Pastore, B Capuani, et al.
Anticancer Research|May 16, 2009
Pathological classification of DCIS and planning of therapeutic managementO Buonomo, P Orsaria, G Contino, et al.
Anticancer Research|July 1, 1996
Clinical utility of CA 72-4 serum marker in the staging and immediate post-surgical management of gastric cancer patientsA Spila, M Roselli, M Cosimelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 20, 2005
Oxaliplatin plus high-dose folinic acid and 5-fluorouracil i.v. bolus (OXAFAFU) versus irinotecan plus high-dose folinic acid and 5-fluorouracil i.v. bolus (IRIFAFU) in patients with metastatic colorectal carcinoma: a Southern Italy Cooperative Oncology Group phase III trialP Comella, B Massidda, G Filippelli, et al.
Cancer Research|November 15, 1996
Correlation between tumor-associated glycoprotein 72 mucin levels in tumor and serum of colorectal patients as measured by the quantitative CA 72-4 immunoassayF Guadagni, M Roselli, M Cosimelli, et al.
Anticancer Research|June 9, 2001
Comparative analysis of CA 242 and CA 19-9 serum tumor markers in colorectal cancer patients. A longitudinal evaluationA Spila, P Ferroni, M Cosimelli, et al.
Lung Cancer (Amsterdam, Netherlands)|May 14, 2004
Correlation between tumor necrosis factor-alpha and D-dimer levels in non-small cell lung cancer patientsF Guadagni, P Ferroni, S Basili, et al.
Tumori|October 9, 2002
Sentinel lymphadenectomy in cutaneous melanomaO Buonomo, A Felici, A V Granai, et al.
AJP Reports|June 9, 2020
Acute Respiratory Decompensation Requiring Intubation in Pregnant Women with SARS-CoV-2 (COVID-19)Jenna S Silverstein, Meghana A Limaye, Sara G Brubaker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2001
A re-evaluation of carcinoembryonic antigen (CEA) as a serum marker for breast cancer: a prospective longitudinal studyF Guadagni, P Ferroni, S Carlini, et al.
Pageof 12